FDA Inspection
American Red Cross Blood ServicesAmerican Red Cross Blood Services – FDA Inspection, Jul 18, 2018
Record Details
This FDA Inspection record concerns American Red Cross Blood Services, with an inspection on July 18, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ab08bae9-838d-476e-9669-cb97b9a4bd5f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1059536
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of American Red Cross Blood Services
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 3, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 8, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 21, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 21, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Services
- FDA Inspection 1305266 - 2026-02-27
- FDA Inspection 1143316 - 2021-06-03
- FDA Inspection 976695 - 2016-07-08
- FDA Inspection 881422 - 2014-05-21
- FDA Inspection 799827 - 2012-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.